The Systemic COronary Risk Estimation (SCORE) system is recommended for the assessment of cardiovascular disease (CVD) death risk in individuals free of CVD.
INTRODUCTION
Arterial stiffness is a biomechanical property of the arterial wall expressed as a change of pressure-volume relationship [1] [2] [3] . Carotid-femoral pulse wave velocity (CFPWV) is the most common method widely used for aortic stiffness measurement [3] . It has been shown that increased CFPWV correlates with an increased risk of cardiovascular death in patients with hypertension [4, 5] and type 2 diabetes (T2D) [6, 7] . Furthermore, CFPWV was an independent predictor of coronary artery disease (CAD) [8] and was recognised as a new risk factor of morbidity and mortality in cardiovascular (CV) disease (CVD) [9] . CFPWV is a useful non-invasive method for measuring the stiffness of the aorta because of its simplicity, repeatability, and accuracy. According to the recent European Society of Cardiology (ESC)/European Society of Hypertension (ESH) guidelines for hypertension, pulse wave velocity (PWV) may be considered in the assessment of arterial stiffness as an integral part of the overall assessment of subjects with hypertension [10] .
The association between CFPWV and a single risk factor such as hypertension is well-known; however, SCORE and CFPWV analysis, although not well documented, indirectly estimates how the PWV affects the 10-year risk of death due to CVDs.
Moreover, CFPWV was proven to predict CVD in a variety of populations independently of traditional CV risk factors [4, 11] . Therefore, the 2013 ESH/ESC guidelines for the management of hypertension recommend measuring CFPWV as a marker of target organ damage in order to improve CV risk prediction [12] [13] [14] . The objective of this study was to evaluate the association between CVD risk factors and CVD risk assessed by Systematic COronary Risk Evaluation (SCORE) and CFPWV measured four years later. Additionally, our goal was to describe the distribution of CFPWV in adult urban Polish population and to estimate the cut-off point for CFPWV which is related to SCORE ≥ 5%.
METHODS

Patients
The study involved 1008 Krakow residents (478 men and 530 women), aged 58.5 ± 6.5 years, and a random (chosen based on a random number generator programme) subsample of 3424 men and 3205 women who participated in Wave 1 and Wave 2 (4.9 years apart) of the Polish part of the Health, Alcohol, and Psychosocial factors in Eastern Europe (HAPIEE) study. In Wave 1, to assess risk factors, the study participants were visited at home to complete a structured questionnaire and were then invited to a clinic for a thorough medical interview to evaluate comorbidities and medications, and for a physical examination. Detailed information on the HAPIEE study, which involved a representative sample of permanent residents of Krakow, was published earlier [15] .
For the present analysis, current smoking was defined as smoking at least one cigarette daily. Prior to the blood pressure (BP) measurement, participants were asked to sit quietly for 5-10 min. BP was measured three times, with a 2-min interval between measurements, which was done using an Omron M5-I device (Omron Healthcare, Kyoto, Japan). Arterial hypertension was defined as a systolic BP ≥ 140 mmHg, or diastolic BP ≥ 90 mmHg, or taking antihypertensive drugs within the last 14 days prior to the examination. History of CAD was established based on a medical interview including documented history of myocardial infarction (MI) or prior cardiac procedures of CAD. T2D diagnosis was based on medical history of T2D treatment or American Diabetes Association criteria. Obesity was diagnosed when body mass index (BMI) ≥ 30 kg/m 2 or waist circumference ≥ 94 cm in men or 80 cm in women. Family history of CAD, stroke, or T2D was considered positive when at least one of the first-degree relatives had a history of at least one of the diseases.
The Jagiellonian University Ethical Committee approved the study, and all the participants provided their written, informed consent (No. KE/99/03/B/284, amendment from March 13, 2008) .
Sample collection and routine laboratory tests
Fasting blood samples (25 mL) were obtained from an antecubital vein and were immediately drawn into the tubes containing 3.2% trisodium citrate. Samples were processed 30 to 60 min after blood collection. Serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglyceride (TG), and glucose were determined using a Cobas 6000™ biochemical analyser (Roche Diagnostics GmbH, Mannheim, Germany). Dyslipidaemias including hypercholesterolaemia and hypertriglyceridaemia were diagnosed in accordance with the European Guidelines on CVD prevention and dyslipidaemias [16] .
Measurement of CFPWV
Carotid-femoral pulse wave velocity was measured in Wave 2 of the HAPIEE study. To assess CFPWV we used the non-invasive, automatic, computerised Complior ® system in accordance with the system protocol. All measurements were performed after a 10 min rest in a supine position (~30°). Mechanical transducers sensitive to deformation of the vessel wall were applied over the common carotid artery and right femoral artery. Then, the distance between the suprasternal notch and the top of the femoral transducer were calculated on the surface of the body with a measuring tape. The CFPWV was calculated by dividing distance (d) of the wave from the carotid to femoral artery over time (t) as shown below [17] :
Carotid-femoral pulse wave velocity values > 10 m/s were defined as "high" according to the current guidelines of the ESC and the ESH [10, 18, 19] .
SCORE assessment
The SCORE system is a calculation of the 10-year risk of a fatal CVD in European countries by sex, age, systolic BP, TC, and smoking status [16, 20] . For eligible participant (without a history of CAD and/or T2D), CVD risk was assessed using the SCORE system calibrated for Poland available on the ESC website (www.heartscore.org; access from January 2007 to December 2009) [21] .
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Statistical analysis
The Shapiro-Wilk test was used to assess the normality of distribution. Distribution of the continuous variables was described by mean and standard deviation (SD) or median and interquartile range (IQR). The Student t test or Mann-Whitney U test was applied to test the between-sex differences. For categorical variables, an absolute number and percentage was presented and the between-sex differences were tested using the c 2 test. Spearman rank correlation coefficients were calculated to test the association between the continuous variables. Stepwise logistic regression analysis was performed to determine the independent predictors of increased CFPWV in the study groups. Despite differences in distribution of characteristics between men and women, the direction and pattern of the association between these variables and CFPWV were homogeneous. Therefore, data were pooled for multivariate analysis including sex as an independent variable. The association between the variables was presented as odds ratio (OR) with corresponding 95% confidence interval (CI). The calibration and discrimination of the developed logistic regression model were assessed using the Hosmer-Lemeshow statistic and the area under the receiver operating characteristic curve (AUC), respectively. Two-sided p-values < 0.05 were considered statistically significant. All calculations were done using STATISTICA version 10 PL software package (StatSoft, Inc., Tulsa, Oklahoma, USA).
RESULTS
Final analysis included 720 participants (378 women and 342 men). At baseline (Wave 1), mean age was 58.1 and 58.8 years, respectively. At Wave 2, participants were older by an average of 4.9 years (4.9 in men and 4.8 in women; Table 1 ). A total of 179 (24.9%) participants had previously diagnosed CAD and 97 had history of T2D, and SCORE was not calculated for these individuals because by definition they were considered high-risk subjects. Therefore, final analysis for SCORE included 229 men and 259 women.
The CFPWV ranged from 2.3 to 37.5 m/s in men and from 2.4 to 31.8 m/s in women. The distribution of CFPWV was skewed in both sexes, and the median was higher in men (12.5 m/s; IQR 10.3-15.7) than in women (11.7 m/s; IQR 10.1-13.7); p = 0.002 (Fig. 1) . For the entire sample CFPWV ranged from 2.3 to 37.5 m/s and the median CFPWV was 12.0 m/s (IQR 10.2-14.7). High CFPWV (> 10 m/s), which is considered abnormal [14, 19] , was observed in 270 (78.9%) men and in 285 (75.4%) women. In the entire sample 555 (77.1%) individuals had high CFPWV.
The distribution of SCORE was skewed particularly in women (Fig. 2) . Median SCORE was higher in men (9.0%; IQR 5.0-14.0) than in women (3.0%; IQR 1.0-6.0); p < 0.001. High risk (SCORE ≥ 5%) was found in 28.6% of women and in 77.7% of men (p < 0.001).
Descriptive statistics for the remaining traits that were analysed are presented according to sex in Table 1 . Smoking and T2D were more prevalent in men, and BP was not significantly higher in men than in women. TC and HDL-C were higher in women, and TGs were higher in men. There was no between-sex difference in LDL-C, and there was no difference in the combined prevalence of dyslipidaemias. The prevalence of obesity was similar in men and women, but the median waist circumference was lower in women, which reflects the between-sex differences in body constitution.
After adjustment for baseline age, the risk of high CFPWV (> 10 m/s) increased with the increase of systolic BP in both sexes and with diastolic BP and the presence of hypertension in women. In women the risk of high CFPWV increased with the increase of BMI and waist circumference. We found a positive association between CFPWV and both blood glucose and TC, but only in male population. In women with no history of CVD or T2D (n = 488), there was a positive relation between the high CFPWV and SCORE (OR 1.42; 95% CI 1.11-1.81 per 1% increase). The relation between the high CFPWV and SCORE was not significant in men (Table 2 ). Triglycerides and smoking as well as other characteristics listed in Table 1 were not associated with high CFPWV.
In individuals without CVD or T2D, after adjustment for age, sex, BMI, blood TG, and glucose, we did not found a continuous relation between SCORE and CFPWV. It was attenuated and remained not significant mainly after inclusion of the age into the model. However, there was a strong relation between high CVD risk (SCORE ≥ 5%) and high CFPWV (OR 2.29; 95% CI 1.17-4.46). Further analysis after subdivision of the group with high CVD risk (SCORE > 5%) changed the average estimates (OR 2.29; 95% CI 1.15-4.55 for SCORE 5%-9%; and OR 2.27; 95% CI 0.92-5.62 for SCORE ≥ 10%).
The calculated CFPWV cut-off value to differentiate between participants with low and high CVD risk (SCORE of < 5% vs. SCORE ≥ 5%) was 11.7 m/s (with 58.6% sensitivity and 71.3% specificity, AUC = 0.68).
DISCUSSION
Knowledge about the association between CFPWV and the result of commonly used CVD risk assessment systems such as the SCORE system is still limited [22] [23] [24] . Because most European countries use different SCORE charts, it is particularly important to assess its results with other measurements. This could improve the quality of CVD predictions in this particular population, including subpopulations, that is, men and women. Therefore, to our knowledge, we are first to demonstrate the association of CFPWV and the SCORE system in any Polish population.
We demonstrated that high CVD risk assessed by the SCORE system predicted high CFPWV at almost five years of follow-up. A continuous relation between SCORE and high CFPWV was attenuated after adjustment for covariates, particularly for age, which suggests a confounding effect that was not strong enough to wave the relation for the range Data presented as number (percentage), mean ± standard deviation or median (interquartile range). BMI -body mass index; BP -blood pressure; CAD -coronary artery disease; CFPWV -carotid-femoral pulse wave velocity; HDL-C -high-density lipoprotein cholesterol; LDL-C -low-density lipoprotein cholesterol; SCORE -Systemic COronary Risk Estimation; TC -total cholesterol; TG -triglycerides of SCORE over 5%. The calculated CFPWV cut-off point of 11.7 m/s allowed us to classify participants of the study to the high CVD risk group with optimal sensitivity and specificity. The SCORE system is a well-recognised tool used to evaluate 10-year CVD risk. On the other hand, the SCORE system was calibrated for specific countries, which allowed adjustment for CVD mortality and exposure to risk factors. Poland is a country with high exposure to CVD risk factors [25] [26] [27] [28] . The most frequent CVD risk factors in Poland are hypercholesterolaemia, hypertension, and cigarette smoking [29] . Our results www.kardiologiapolska.pl Carotid-femoral pulse wave velocity and the SCORE system are in accordance with another study which demonstrated that arterial stiffness (assessed by CFPWV among other parameters) was also positively associated with SCORE, but in that study the authors did not attempt to assess a cut-off point for CFPWV, which allowed to classify the participants into the high and low CVD risk groups [22] .
In the 2013 ESC guidelines for the management of arterial hypertension, a measurement of CFPWV was recommended in all individuals with arterial hypertension [14, 19] . However, in the 2018 ESH/ESC guidelines there was no such recommendation. Nevertheless, PWV is considered as one of the key factors influencing CV risk in patients with asymptomatic hypertension-mediated organ damage [10] . Moreover, CFPWV over 10 m/s was for many years considered a risk factor for CVD [14, 19] . Greve et al. [30] analysed the data from over 2500 patients and demonstrated an increase in the CFPWV associated with atherosclerotic plaques and increased rate of albuminuria to creatinine ratio depending on the high and very high risk assessed by the SCORE system and Framingham risk scale. The authors emphasised that PWV better predicted CVD complications in high-risk subjects [30] . It was reported that PWV is associated with the severity of CAD: 11.13 ± 0.91 m/s, 15.22 ± 1.11 m/s, and 19.30 ± 2.05 m/s for one-, two-, and three-vessel CAD, respectively [31] . Similarly, Kopeć et al. [32] observed that increased aortic wall stiffness (aortic PWV) was associated with the severity of CAD. Invasive measurements of aortic PWV were linked with worse endothelial function in patients with angiographically confirmed CAD, independent of sex [32] . Higher CFPWV was also observed in individuals with microvascular angina compared to a healthy control group (9.3 m/s vs. 8.2 m/s, respectively) [33] . Recent studies show that the assessment of PWV as an indicator of arterial stiffness is still a widely used parameter [34, 35] .
We have several limitations to acknowledge. The most important is that we were not able to adjust for the baseline CFPWV, which did not allow us to address the problem of overtime change and limited our ability to address the problem of causality. Also, there was no information on changes in the exposure to risk factors after the baseline examination, so their directions and magnitudes could not be evaluated. Second, age as a CVD risk factor interferes with arterial stiffness and, by definition, is associated with the results of the SCORE system. Third, our study population was not representative of the entire Polish population and involved a local population of residents of one city (second largest city in Poland). Further, earlier observations of the HAPIEE cohort showed that study participants were healthier compared to non-participants. Still, nearly 6% of the total sample examined at baseline did not survive to participate in PWV measurement at five years of follow-up [36] . The latter could lead to elimination of the high-risk group, and it is possible that it could attenuate slightly the relation between SCORE and CFPWV. Fourth, as mentioned above, the SCORE system appeared to overestimate CVD risk in the Polish HAPIEE sample [37] . Also, classification into the groups of high and very high CVD risk could be biased as compared to real risk. Finally, the expert consensus for measurement of aortic stiffness recommends use of 80% of the direct carotid-femoral distance as the most accurate distance estimate [18] ; however, we performed our measurements using the protocol of the device used in the study (Complior ® system). Our study is the first to describe the distribution of CFPWV in the adult urban Polish population. SCORE ≥ 5% predicted high CFPWV in 4.9 years of follow-up, which was independent of other risk factors, and CFPWV > 11.7 appeared to be most valid in relation to high CVD risk. Table 1 www.kardiologiapolska.pl
